Lundbeck
HLUN-B.CO
#2508
Rank
NZ$9.85 B
Marketcap
$10.30
Share price
-0.93%
Change (1 day)
20.33%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$1.00 Billion

According to Lundbeck 's latest financial reports the company's total debt is NZ$1.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.97 B-23.18%
2022-12-31NZ$1.26 B6.67%
2021-12-31NZ$1.18 B-34.37%
2020-12-31NZ$1.80 B-15.23%
2019-12-31NZ$2.13 B
2018-12-31N/A-100%
2017-12-31NZ$12.93 M-96.66%
2016-12-31NZ$0.38 B-51.99%
2015-12-31NZ$0.80 B15.84%
2014-12-31NZ$0.69 B43.2%
2013-12-31NZ$0.48 B18.27%
2012-12-31NZ$0.41 B-3.99%
2011-12-31NZ$0.42 B-4.01%
2010-12-31NZ$0.44 B-51.56%
2009-12-31NZ$0.92 B49.59%
2008-12-31NZ$0.61 B29.39%
2007-12-31NZ$0.47 B32.03%
2006-12-31NZ$0.36 B305.53%
2005-12-31NZ$88.93 M-15.04%
2004-12-31NZ$0.10 B